Quality of care from the patient's perspective in pediatric diabetes care

Related Experiment Videos

Lena Hanberger1, Johnny Ludvigsson, Sam Nordfeldt

  • 1Diabetes Research Centre, Division of Pediatrics, IMK, Faculty of Health Sciences, S-581 85 Linköping, Sweden. lena.hanberger@lio.se

Insights

This study found high perceived quality of care for type 1 diabetes patients, but identified needs for better patient information, access, and reduced waiting times. Improvements are crucial for diabetes management.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Health Services Research

Background:

  • Quality of care is crucial for managing chronic conditions like type 1 diabetes in pediatric populations.
  • Assessing patient perspectives is vital for identifying areas of strength and improvement in healthcare delivery.

Purpose of the Study:

  • To investigate the perceived quality of diabetes care among young patients (<20 years) with type 1 diabetes.
  • To identify specific factors influencing perceived care quality and their subjective importance.
  • To explore correlations between perceived care quality and clinical outcomes or patient demographics.

Main Methods:

  • A validated questionnaire, Quality of Care from the Patient's Perspective (QPP), was administered to 400 type 1 diabetes patients.
  • Additional context-specific items were included to gather detailed feedback.
  • Response rates were 71% for parents and 65% for adolescents.

Main Results:

  • High perceived quality of care was reported, particularly regarding privacy, respect, atmosphere, continuity, and participation.
  • Lower perceived quality with higher importance was noted for information on results, self-care, access, and waiting times.
  • Parents reported higher perceived reality and importance of care aspects compared to adolescents.

Conclusions:

  • The QPP instrument, augmented with specific items, effectively captures patient-reported quality of care.
  • Improvements are needed in patient information, access to care, and waiting times for pediatric type 1 diabetes management.
  • Addressing these areas can enhance the overall quality of diabetes care for young patients and their families.

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...